We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

What To Watch For In 2nd Meningitis Murder Case

Law360, Boston (September 18, 2017, 4:24 PM EDT) -- Prosecutors who came close to convicting a pharmacist of second-degree murder for his role in the 2012 meningitis outbreak may have an even stronger case against his top deputy when the second drug-contamination murder trial begins in Boston this week.

The reason is simple: Glenn Chin, a supervisory pharmacist at the New England Compounding Center, is accused of actually making the deadly drugs.

Like the first trial against Chin’s boss, NECC owner and head pharmacist Barry Cadden, the second trial will try to answer questions that have haunted the families of the 64 people who died and the 700 who were...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS